安大略省临床试验领导层的雄心勃勃的愿景.pdf

《安大略省临床试验领导层的雄心勃勃的愿景.pdf》由会员分享，可在线阅读，更多相关《安大略省临床试验领导层的雄心勃勃的愿景.pdf（12页珍藏版）》请在三个皮匠报告上搜索。

1、AdvancingClinical Trialsin Ontario Updates from Clinical Trials OntariosOntario Leadership Table for Clinical TrialsDr.Brad WoutersChair,Ontario Leadership Table for Clinical Trials,CTOExecutive Vice President,Science&Research,UHNOntario is a powerhouse in health research19of Canadas Top 40 Research

2、 Hospitals2,200Biotech,medical device,and digital health companies22,000Highly-skilled researchers and staff$1.73 BInvestment in health research56,000Jobs in medical devices,drugs,and pharmaceuticals1,900+4,600Active clinical trials2 more per capita than US$466 MIndustry investment in trialsActive c

3、linical trials63,200+Publications in 20182022(18%in Top Ten Percent)1+14University+Affiliated Hospitals#1Life sciences research hub in Canada#2Number of clinical trials among North American HubsThe OpportunityOntario and Canada as a destination for life sciences and clinical trials innovation5,000+E

4、nrolments in 2023(3,970 thus far in 2024)800+Active interventional trials(53%supported by industry)290+New trials activated annually1,000+Highly-qualified personnel supporting trialsMembershipOntarios top research-intensive hospitalsCanadas leading pharmaceutical companiesGovernment EngagementMinist

5、ry of Colleges and UniversitiesMinistry of Economic Development,Job Creation and TradeMinistry of HealthOntario Leadership Table for Clinical Trials Driving transformational change in clinical trial conductTimely Access to Trials TOP PRIORITYReduce trial start-up time to 45 days RecruitmentDecentral

6、ize recruitment and enable pathways for patient activationHealth Data AccessLeverage data platforms to facilitate research and decision-makingRare DiseaseCapitalize on federal governments new rare disease strategy;improve access to therapies and clinical trials in rare diseaseCollaborative AdvocacyI